These tumor-derived mesenchymal stromal cells (TuMSC) exhibited a proinflammatory phenotype and responded to stimulation by tumor cells with a strong interleukin (IL)-8 release and with CD54 upregulation, respectively. Here, ICAM1 is linked to neoplasm.